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Background: To understand the clinical characteristics and the diagnostic procedures in pediatric patients with
eosinophilic esophagitis and to evaluate the sensitivity of the patients to food and inhalant allergens. A
cross-sectional study was performed in 35 children with eosinophilic esophagitis during the time period from
January 2010 to January 2011. The clinical and epidemiological data were obtained using a questionnaire and
medical chart analysis. The body mass index for age was used for the nutritional evaluation (via the Z score). The
sensitivity to foods and inhalants was evaluated by performing a skin prick test and atopy patch test.
Results: Patients (35 in total, median age 10 years) with a diagnosis of eosinophilic esophagitis were evaluated. The
most prevalent symptoms in the patients were vomiting (71.4%) and abdominal pain (51.4%). Endoscopic
alterations were observed in 97.2% of the patients. A good nutritional state was observed in 82.8% of the children.
The tests demonstrated the presence of food sensitivities and/or aeroallergens in 27 (77.1%) patients, whereas 8
(22.9%) patients did not test positive in any of the tests performed. Among the patients with positive tests, 24
(68.5%) exhibited sensitivity to aeroallergens and 16 (45.7%) were sensitive to foods. The comparison between the
sensitive and insensitive groups displayed statistically significant results with respect to sex, symptom prevalence,
and 24-hour esophageal pH monitoring.
Conclusions: The patients evaluated in this study displayed clinical characteristics of eosinophilic esophagitis similar
to those reported in the literature. The sensitivity to foods determined by the tests was less than that observed in
prior studies; however, a marked sensitivity to aeroallergens was observed. The different allergen sensitivity profiles
observed in this study suggests that, similar to asthma, the eosinophiic esophagitis disease may exhibit several
phenotypes.
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Eosinophilic esophagitis (EoE) is defined as an immune-
mediated chronic disease characterized by symptoms of
esophageal dysfunction combined with the histological
presence of an eosinophilic inflammatory process dem-
onstrating at least 15 eosinophils (EOS) per high power
field (HPF) in the absence of other eosinophilic syndromes
[1,2]. Eosinophilic esophagitis was first described in 1978,
and although the disease is considered rare, a substantial* Correspondence: gesmar@famed.ufu.br
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unrestricted use, distribution, and reproductioincrease in the number of EoE cases has been reported in
the last decade [3,4].
To diagnose EoE, it is necessary to exclude gastroesoph-
ageal reflux disease (GERD) as the cause of the esophageal
eosinophilia. The GERD diagnosis is excluded by moni-
toring the pH acidity of the esophagus (24-hour pH
monitoring), or following the failure of treatments with
high doses of a proton-pump inhibitor (PPI) for at least
4 weeks, resulting in the persistence of eosinophils at
greater than 15 EOS/HPF [1,2].
Little is known about the incidence of EoE. A prospect-
ive study performed in Denmark reported the prevalencede et al.; licensee BioMed Central Ltd. This is an open access article distributed
tribution License (http://creativecommons.org/licenses/by/2.0), which permits
n in any medium, provided the original work is properly cited.
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[5]. In another study, an increase in the prevalence of the
disease in Australian children was observed (from 0.05 to
0.89 cases per 10,000) [6]. A population survey performed
in Sweden demonstrated the disease in approximately 1%
of the population studied [7]. Another study reported that
8% to 10% of patients with GERD who were unresponsive
to treatment with the PPI produced results compatible
with a diagnosis of EoE [8].
EoE exhibits diverse clinical manifestations with the
onset of symptoms at a variety of different ages. Infants
and young children may display intolerance or may re-
fuse food, or GERD symptoms may persist even after ap-
propriate treatment [9]. Older children and adolescents
may exhibit abdominal pain, vomiting, dysphagia, or im-
paction with solid foods [10].
Little is known about the pathogenesis of EoE, how-
ever, studies indicate similarities between the inflam-
matory process observed in the esophagus in EoE and
that described for asthma and atopic dermatitis [11].
Several publications suggest that EoE is associated with
food allergies, and clinical and histological improve-
ments have been observed following the use of elemen-
tal diets [4,12].
Because of the lack of information regarding EoE, spe-
cially in Brazil, this study investigated the clinical char-
acteristics of pediatric patients with EoE and evaluated
the frequency of sensitivity to foods and inhalant aller-
gens among the patients referred to our clinic.
Methods
From January 2010 to January 2011, patients in the
pediatric age range with a diagnosis of EoE and who
were cared for at the Pediatric Gastroenterology and
Food Allergy Clinic of the Clinical Hospital of Federal
University of Uberlândia (HC-UFU) were invited to par-
ticipate in this study. The exclusion criteria included
the refusal to perform a phase of the study, patients
who displayed a clinical improvement and histological
normalization during the study period, or the presence
of other chronic diseases (cystic fibrosis, cerebral palsy,
chronic kidney disease, and severe heart disease). The
guardians for the patients signed the informed consent
forms.
The diagnosis of EoE was performed using the estab-
lished consensual clinical and histological criteria, which
consider the presence of more than 15 EOS/HPF in four
biopsy samples [2].
A questionnaire was used for the clinical evaluation, and
an assessment of the patient’s and the parent’s history of
asthma, rhinitis, and atopic dermatitis was performed in
addition to the analysis of data related to the date of
diagnosis, endoscopy, biopsy, and 24-hour pH monitoring
tests [13]. The patients underwent an anthropometricevaluation for weight and height for infants and evalu-
ated according to body mass index for children after
two years, using the Z score for age (WHO, World
Health Organization) [14].
The endoscopies were performed by 2 pediatric endos-
copists from the HC-UFU, and biopsies of the upper,
middle, and lower thirds of the esophagus in addition to
the stomach and duodenum were performed. For the
diagnosis of EoE, in addition to the presence of 15 EOS/
HPF in the histological evaluation of the esophagus, the
biopsies performed in the stomach and duodenum did
not indicate an above normal number of eosinophils at
any location [2].
The patients underwent a 24-hour pH-monitoring
exam. The adopted normalcy criterion was based on the
reflux index and was considered acceptable when the
esophageal pH was below 4 for less than 4.2% of the moni-
toring time [15]. All the patients were treated with the PPI
(2 mg/kg/day) for 8 weeks. A new endoscopy was then
performed, and a diagnosis of EoE was established when
the histological evaluation showed a persistence of more
than 15 EOS/HPF [2].
After filling out the questionnaire, the patients under-
went a skin prick test (SPT) to evaluate their immediate
sensitivity to foods and inhalants, and an atopy patch test
was used to evaluate delayed sensitivities or sensitivities
not measured using the IgE allergy test.
To perform the prick test, standardized allergenic ex-
tracts (Immuntech, Rio de Janeiro, Brazil) of the follow-
ing aeroallergens were used: mites (Dermatophagoides
pteronyssinus, Dermatophagoides farinae, and Blomia
tropicalis), cockroaches (Blattella germanica), airborne
fungi (Alternaria sp., Aspergillus sp., Cladosporium sp.,
and Penicillium sp.), grasses, and dog and cat epithelia.
The same procedure was used for the following foods:
milk, egg white, soybean, wheat, corn, beef, pork, chicken,
fish, oats, potato, beans, and rice. The positive control was
performed using histamine chloride (10 mg/mL) diluted
in physiological saline containing 50% glycerol, and the
negative control was performed using the standard diluent
used in the allergenic extracts. The test was read after 15
minutes by measuring the wheals (mm) using a graduated
ruler. Papules with an average diameter measuring 3 mm
larger than the negative control was considered prick test
positive. The tests were performed by an appropriately
trained experienced professional.
The food atopy patch test was performed using the
following fresh foods: powdered skim cow’s milk, egg
white, infant soy formula, wheat flour, corn, beef, pork,
chicken, and saltwater fish. The meats were cooked in
distilled water for 10 minutes before administration and
were prepared at a dilution of 2 grams of food per 2 ml
of isotonic saline solution [16]. An appropriately trained
nutrition professional prepared and handled the food in
Table 1 Clinical characteristics of the patients with EoE
treated at the HC-UFU
Data Values
Median age in years (variance) 10 (1.6 a 15.3)
Male Sex (%) 20 (57.1)
Parental history of atopy (%) 18 (51.4)
Personal history of atopy (%)
Asthma 21 (60)
Rhinitis 26 (74.2)
Atopic dermatits 15 (42.8)
Mean age at diagnosis (SD) 7.4 (3.8)
Nutritional status (%)
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cision scale was used. The extracts were placed on filter
paper and were attached to aluminum chambers (Finn
Chamber, Phoenix, United States) measuring 8 mm in
diameter, which were adhered to the upper region of the
patient’s back. The extracts were removed after 48
hours, and a reading was performed 72 hours after the
material was put in place. The evaluation was performed
by the same researcher and at the same location where
the containers were placed following the technique de-
scribed by Spergel et al. [16].
The Ethics Committee of Federal University of Uberlândia
approved this study. The results were analyzed using de-
scriptive statistics to characterize the group of evaluated
patients, and to compare the sensitive and insensitive
groups, the Mann–Whitney test was used with p < 0.05.
The data were analyzed using the SPSS for Windows,
version 17.0 software (SPSS, Chicago, IL).Results
Of the 45 patients with a diagnosis of EoE who were
treated during this period, 10 were excluded; 4 were ex-
cluded because of inactivity of the disease, 5 because they
suffered from cerebral palsy, and 1 for refusing to undergo
the prick test.
Of the 35 patients who were analyzed, 20 (57.1%) were
male. The median age was 10 years with a variance of
1.6 to 15.3 years. At diagnosis, the mean age was
7.4 years with a standard deviation of 3.8 years, and for
the age at the onset of symptoms, as reported by the
parents; the median was 2.3 years with a variance of 1
month to 13 years. A history of atopy in the patient and in
the parent was observed in 18 (51.4%) of the evaluated
patients. Good nutritional conditions were observed in 29
(82.8%) of the individuals. Underweight was observed in 2
(5.7%) of the patients, and overweight was observed in 4
(11.4%) of the patients. These data are shown in Table 1.
The most frequent symptoms were vomiting in 25
(71.4%) patients and abdominal pain in 18 (51.4%) pa-
tients. The endoscopies examinations revealed alterations
in 34 (97.2%) patients, and the following alterations were
the most common: loss of the vascular pattern with an ad-
herent, white exudate (in 24 (68.5%) patients), vertical
lines, and opalescent mucosa. The histological evaluation
showed that the presence of EOS varied from 20 to 150
EOS/HPF, with a median of 40 EOS/HPF. The symptom
data and the endoscopic findings are shown in Figure 1.
The 35 patients underwent an evaluation of the esopha-
geal pH for 24 hours (pH monitoring) and values within
normal ranges were observed in 26 (74.2%) patients.
The tests demonstrated a positive result for sensitivity to
foods and/or aeroallergens in 27 (77.1%) of the evaluated
patients. Among the sensitive patients, 24 (68.5%) weresensitive to at least one inhalant, and mites and dog epi-
thelia were the most common sensitivities observed.
The skin prick test and the food atopy patch test data
demonstrated 16 (45.7%) patients with sensitivity to
foods. The foods with the highest frequency of sensitivity
were cow’s milk, soybean, and chicken. The distribution
of positivity in the tests is shown in Table 2.
A negative result for every sensitivity test was observed
in 8 (22.9%) patients. Significant differences related to
the age ranges were not observed between the sensitive
patients and the non-sensitive patients; however, statisti-
cally significant (p < 0.05) differences in the distribution
of sex, clinical presentation, 24-hour pH monitoring,
and the endoscopic results were observed between the 2
groups (Table 3).
Discussion
EoE is a chronic inflammatory disease of the esophagus
that has sparked the interest of doctors and scientists all
around the world because of the increased number of
cases in children and adults [1,17,18]. In this study, we
investigated pediatric patients with EoE in our environ-
ment and determined whether our population exhibits
the clinical characteristics and allergen sensitivities simi-
lar to the data reported in the literature.
Consistent with the majority of published studies involv-
ing patients with EoE, we observed a predominance of the
disease in males [1,12,18,19]. The patients exhibited ele-
vated prevalence of asthma, rhinitis, atopic dermatitis, and
a high parental history of allergies, which is similar to ob-
servations reported in previous studies [1,2,18].
The reason for the lengthy time interval between the
onset of the symptoms and the diagnosis of the disease
observed in this study may be that EoE exhibits a symp-
tomatology similar to other common diseases, such as
Table 2 Distribution of the positivity of the tests
performed to evaluate food sensitivity in patients with
EoE
Foods APT SPT APT + SPT
n(%) n(%) n(%)
Cow’s Milk 4(11.4) 4(11.4) 8(22.8)
Soybean 6(17.1) 2(5.7) 8(22.8)
Chicken 4(11.4) 1(2.8) 5(14.2)
Fish 4(11.4) 1(2.8) 5(14.2)
Beef 4(11.4) 0(0.0) 4(11.4)
Pork 2(5.7) 1(2.8) 3(8.5)
Corn 2(5.7) 0(0.0) 2(5.7)
Egg White 1(2.8) 2(5.7) 3(8.5)
Wheat 1(2.8) 0(0.0) 1(2.8)
SPT skin prick test.
APT atopy patch test.
B)
A)
Figure 1 Prevalence of symptoms and endoscopic findings in patients with EoE treated in HC-UFU. A. Prevalence of symptoms findings in
patients with EoE treated in HC B. Prevalence of endoscopic findings in patients with EoE treated in HC.
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in which the average time between the onset of the EoE
symptoms and the first diagnostic endoscopy was 36
months [20]. However, other factors may be associated
with the diagnostic delay, such as the doctors’ lack of
knowledge of the disease and the need for specialized ex-
aminations, such as pediatric endoscopy and esophageal
biopsies, which are performed only in referral centers.
We observed that only 2.8% of the endoscopies exhib-
ited a normal appearance, which is in contrast to the re-
sults obtained in a retrospective study involving 381
children in which 32% of the endoscopic examinations
of the patients with EoE were within the normal range
[18]. The standardization of the endoscopic examination,
combined with the routine performance of more than 1
biopsy and the fact that all of the examinations were
performed by the same 2 professionals at the referral
center, may have contributed to the higher diagnostic
rates. Caution when routinely performing esophageal,
stomach, and duodenum biopsies in all pediatric patients
Table 3 Comparative analysis of the descriptive data of
the patients with EoE cared for at the HC-UFU who were
both sensitized and non sensitized to the allergic tests
performed
Data Non sensitized Sensitized p-value*
n(%) n(%)
Male sex 2(25.0%) 18(66.6%) 0.0194
Food impactation 0(0.0%) 4(14.8%) 0.0002
Vomiting 8(100%) 18(66.6%) 0.0002
Normal pH monitoring 8(100%) 17(62.9%) 0.0001
White exsudate 2(25.0%) 21(77.7%) 0.0023
Opacity 1(12.5%) 12(44.4%) 0.0347
*Mann Whitney test (significante p value <0.05).
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in other studies [21,22].
The majority of the patients (82.8%) did not exhibit
alterations in their growth curves at diagnosis, which is
consistent with a study in which the patients with EoE
were monitored for more than 10 years. In the study, a
relevant nutritional impact was not observed in the ma-
jority of the individuals, even among those patients still
exhibiting symptoms and not demonstrating histological
remission [23]. However, the disease only affects the
esophagus and spares other segments of the gastrointes-
tinal tract, which could explain why the disease did not
affect the growth curve of patients.
In our study, the majority of the patients were school-
aged children and pre-adolescents with a median age
similar to that of other studies [2,18,19]. In 1 of our
patients, the diagnosis was performed at less than 24
months of age, and the refusal to eat made it necessary
to perform a gastrostomy to maintain the nutritional sta-
tus of the patient.
In the majority of our patients, the symptoms mimicked
GERD, such as vomiting and abdominal pain, which are
generally persistent even with long-term treatment with
PPI, and this finding is currently considered a criterion for
a clear diagnosis of EoE [1,18,24]. Similar to other reports,
a large number of the patients who underwent the 24-
hour pH monitoring evaluation exhibited and reflux index
within the normal range, excluding the acidic exposure of
the esophagus as a cause of EoE [11]. Currently, the con-
comitance of EoE and GERD is well-documented, which
explains a number of the altered pH monitoring exami-
nations; however, the patients do not exhibit a clinical
or histological response to the PPI [1]. Dysphagia and
sudden impaction in asymptomatic individuals have been
reported in a significant number of patients, usually in
older children and adults [25].
The physiopathology of EoE has not been completely
described, and further information is needed to under-
stand this disease. Currently, evidence supports thepresence of an altered immune response as a possible
causal factor of the disease; however, the existence of an
associated antigen has not been confirmed [1]. The
remission of the clinical and histological profile of EoE
with the use of elemental diets is strong evidence for
associating EoE with an food allergy [1,2,23,26]. In
addition, other studies have demonstrated clinical and
histological improvements using empirical dietary ex-
clusions or dietary exclusions guided by allergy testing,
suggesting that a food antigen may be responsible for
the immune alteration described for EoE [12,16,25,27].
Despite reports in the literature of remission following
different elimination diets, in the daily practice of primary
care in public hospitals or private offices, a strict diet is
difficult to apply and may have a major impact on the
quality of life of the pediatric patients and their families
[28]. Therefore, the use of allergy tests to evaluate the
immediate and delayed allergic sensitivity to foods has
been suggested by a number of authors, which allows
the provision of a directed elimination diet with fewer
repercussions in the daily and social life of these pa-
tients [2,5]. In our patients, the tests revealed fewer
sensitivities to foods compared to other studies using
the same techniques [12,16,29].
Because this report describes a cross-sectional study, it
does not allow for the claim that sensitivity actually
translates into food allergy. To prove this claim, it is ne-
cessary to perform a series of endoscopies and biopsies
to demonstrate the role of each food in the genesis of the
esophageal inflammatory process, which is recognized as
the gold standard for establishing the relationship between
EoE and food allergy [12].
Pertaining to the involvement of inhalants in the
pathogenesis of EoE, an experimental study in rats using
a placebo control demonstrated that esophageal hypersen-
sitivity was simultaneous with the development of pul-
monary inflammation, particularly in genetically modified
animals that were eotaxin-3 and interleukin 5-positive,
demonstrating that similar to asthma, sensitivity to inhal-
ants might be involved in the pathogenesis of the disease
[30]. Other studies suggest the participation of inhalants
in the activation of the disease during seasons associated
with high levels of pollen [31].
In our patients, there was a notable positivity for the
sensitivity to inhalants, similar to what was observed in
the prick test. We stress the need for further studies to
understand the actual association of inhalants with EoE.
Notably, a large proportion of the patients were carriers
of other atopic diseases, such as asthma and rhinitis, and
it was not possible to establish whether the positivity in
the test was because of one of these diseases, EoE, or all
of the above.
The observation that one group of patients exhibited
allergen sensitivity and another group did not exhibit
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exhibits different inflammatory patterns that lead to a
common clinical presentation; therefore, it is possible
for the disease to exhibit different phenotypes.
Whereas the cause of the immune alteration responsible
for esophageal inflammation in EoE is still under discus-
sion, we need to offer our patients the most effective treat-
ment possible with the smallest impact on the quality of
life. The consensus recommended treatment, in addition to
an elimination diet, is the administration of topical cortico-
steroids that are swallowed, which was employed in all of
the patients who participated in this study [1,2,32]. To
realize the full impact of EoE in children, some authors
note that the histological findings and professional percep-
tion are important for patient assessment through the de-
velopment of quality of life questionnaires [33].
Conclusions
In conclusion, the patients evaluated in this study exhibited
clinical characteristics that were similar to other cases of
EoE described in the literature, demonstrating an important
association with other allergic diseases that also exhibit an
alteration in the immune system’s expression. The need for
future studies to gain further insight into the pathogenesis
of this disease does not prevent us from offering a treat-
ment that could ensure an improvement in the quality of
life and reduce the chance of acute events related to EoE.
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